Sally Shaywitz, MD

Shaywitz SE, Shaywitz JE, Shaywitz BA. Dyslexia in the 21st century. Current Opinion In Psychiatry 2021, 34: 80-86. PMID: 33278155, DOI: 10.1097/YCO.0000000000000670.

Shaywitz SE. Dyslexia. The New England Journal Of Medicine 1998, 338: 307-12. PMID: 9445412, DOI: 10.1056/NEJM199801293380507.

Shaywitz BA, Sullivan CM, Anderson GM, Gillespie SM, Sullivan B, Shaywitz SE. Aspartame, behavior, and cognitive function in children with attention deficit disorder. Pediatrics 1994, 93: 70-5. PMID: 7505423.

Shaywitz SE, Shaywitz BA, Fletcher JM, Escobar MD. Prevalence of reading disability in boys and girls. Results of the Connecticut Longitudinal Study. JAMA 1990, 264: 998-1002. PMID: 2376893.

Shaywitz BA, Shaywitz SE, Sebrechts MM, Anderson GM, Cohen DJ, Jatlow P, Young JG. Growth hormone and prolactin response to methylphenidate in children with attention deficit disorder. Life Sciences 1990, 46: 625-33. PMID: 2308471, DOI: 10.1016/0024-3205(90)90131-a.

Sebrechts MM, Shaywitz SE, Shaywitz BA, Jatlow P, Anderson GM, Cohen DJ. Components of attention, methylphenidate dosage, and blood levels in children with attention deficit disorder. Pediatrics 1986, 77: 222-8. PMID: 3945535.

Raskin LA, Shaywitz SE, Shaywitz BA, Anderson GM, Cohen DJ. Neurochemical correlates of attention deficit disorder. Pediatric Clinics Of North America 1984, 31: 387-96. PMID: 6728523, DOI: 10.1016/s0031-3955(16)34584-9.

Shaywitz SE, Hunt RD, Jatlow P, Cohen DJ, Young JG, Pierce RN, Anderson GM, Shaywitz BA. Psychopharmacology of attention deficit disorder: pharmacokinetic, neuroendocrine, and behavioral measures following acute and chronic treatment with methylphenidate. Pediatrics 1982, 69: 688-94. PMID: 7079034.

Young JG, Cohen DJ, Shaywitz SE, Caparulo BK, Kavanagh ME, Hunt RD, Leckman JF, Anderson GM, Detlor J, Harcherik D, Shaywitz BA. Assessment of brain function in clinical pediatric research: behavioral and biological strategies. Schizophrenia Bulletin 1982, 8: 205-35. PMID: 6180470, DOI: 10.1093/schbul/8.2.205.